A 12-month randomized, open-label study of the metabolic effects of olanzapine and risperidone in psychotic patients: Influence of valproic acid augmentation

Herbert Y. Meltzer*, Stefania Bonaccorso, William V. Bobo, Yuejin Chen, Karuna Jayathilake

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

31 Scopus citations

Fingerprint

Dive into the research topics of 'A 12-month randomized, open-label study of the metabolic effects of olanzapine and risperidone in psychotic patients: Influence of valproic acid augmentation'. Together they form a unique fingerprint.

Neuroscience

Pharmacology, Toxicology and Pharmaceutical Science

INIS

Psychology